Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma.

Blombery P, Birkinshaw RW, Nguyen T, Gong JN, Thompson ER, Xu Z, Westerman DA, Czabotar PE, Dickinson M, Huang DCS, Seymour JF, Roberts AW.

Br J Haematol. 2019 Sep;186(6):e188-e191. doi: 10.1111/bjh.16069. Epub 2019 Jun 24. No abstract available.

PMID:
31234236
2.

First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study.

Khot A, Brajanovski N, Cameron DP, Hein N, Maclachlan KH, Sanij E, Lim J, Soong J, Link E, Blombery P, Thompson ER, Fellowes A, Sheppard KE, McArthur GA, Pearson RB, Hannan RD, Poortinga G, Harrison SJ.

Cancer Discov. 2019 Aug;9(8):1036-1049. doi: 10.1158/2159-8290.CD-18-1455. Epub 2019 May 15.

PMID:
31092402
3.

CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencing.

Markham JF, Yerneni S, Ryland GL, Leong HS, Fellowes A, Thompson ER, De Silva W, Kumar A, Lupat R, Li J, Ellul J, Fox S, Dickinson M, Papenfuss AT, Blombery P.

Sci Rep. 2019 Apr 23;9(1):6426. doi: 10.1038/s41598-019-42858-8.

4.

Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Blombery P, Thompson ER, Prince HM.

Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S-64S. doi: 10.1097/PRS.0000000000005570. Review.

PMID:
30817557
5.

UK registry analysis of donor substance misuse and outcomes following pancreas transplantation.

Thompson ER, Irwin EA, Trotter P, Ibrahim IK, Tingle SJ, White SA, Manas DM, Wilson CH.

Clin Transplant. 2019 Mar;33(3):e13481. doi: 10.1111/ctr.13481. Epub 2019 Feb 12.

PMID:
30659654
6.

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia.

Blombery P, Anderson MA, Gong JN, Thijssen R, Birkinshaw RW, Thompson ER, Teh CE, Nguyen T, Xu Z, Flensburg C, Lew TE, Majewski IJ, Gray DHD, Westerman DA, Tam CS, Seymour JF, Czabotar PE, Huang DCS, Roberts AW.

Cancer Discov. 2019 Mar;9(3):342-353. doi: 10.1158/2159-8290.CD-18-1119. Epub 2018 Dec 4.

PMID:
30514704
7.

Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States.

Lin-Brande M, Nazemi A, Pearce SM, Thompson ER, Ashrafi AN, Djaladat H, Schuckman A, Daneshmand S.

Urol Oncol. 2019 Mar;37(3):180.e1-180.e9. doi: 10.1016/j.urolonc.2018.11.003. Epub 2018 Nov 25.

PMID:
30482434
8.

Perioperative implications of common and newer psychotropic medications used in clinical practice.

Kaye AD, Kline RJ, Thompson ER, Kaye AJ, Terracciano JA, Siddaiah HB, Urman RD, Cornett EM.

Best Pract Res Clin Anaesthesiol. 2018 Jun;32(2):187-202. doi: 10.1016/j.bpa.2018.06.002. Epub 2018 Jul 2. Review.

PMID:
30322459
9.

Mutations in RECQL are not associated with breast cancer risk in an Australian population.

Li N, Rowley SM, Goode DL, Amarasinghe KC, McInerny S, Devereux L; LifePool Investigators, Wong-Brown MW, Lupat R, Lee JEA, Hughes S, Thompson ER, Zethoven M, Li J, Trainer AH, Gorringe KL, Scott RJ, James PA, Campbell IG.

Nat Genet. 2018 Oct;50(10):1346-1348. doi: 10.1038/s41588-018-0206-9. No abstract available.

PMID:
30224651
10.

The Emerging Role of Gas Plasma in Oncotherapy.

Dai X, Bazaka K, Richard DJ, Thompson ERW, Ostrikov KK.

Trends Biotechnol. 2018 Nov;36(11):1183-1198. doi: 10.1016/j.tibtech.2018.06.010. Epub 2018 Jul 20. Review.

PMID:
30033340
11.

Early versus late ureteric stent removal after kidney transplantation.

Thompson ER, Hosgood SA, Nicholson ML, Wilson CH.

Cochrane Database Syst Rev. 2018 Jan 29;1:CD011455. doi: 10.1002/14651858.CD011455.pub2. Review.

12.

Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.

Li N, Rowley SM, Thompson ER, McInerny S, Devereux L, Amarasinghe KC, Zethoven M, Lupat R, Goode D, Li J, Trainer AH, Gorringe KL, James PA, Campbell IG.

Breast Cancer Res. 2018 Jan 9;20(1):3. doi: 10.1186/s13058-017-0929-z.

13.

Sustained frontal midline theta enhancements during effortful listening track working memory demands.

Wisniewski MG, Iyer N, Thompson ER, Simpson BD.

Hear Res. 2017 Nov 27. pii: S0378-5955(17)30368-4. doi: 10.1016/j.heares.2017.11.009. [Epub ahead of print]

PMID:
29249546
14.

Canary: an atomic pipeline for clinical amplicon assays.

Doig KD, Ellul J, Fellowes A, Thompson ER, Ryland G, Blombery P, Papenfuss AT, Fox SB.

BMC Bioinformatics. 2017 Dec 15;18(1):555. doi: 10.1186/s12859-017-1950-z.

15.

ASXL1 c.1934dup;p.Gly646Trpfs*12-a true somatic alteration requiring a new approach.

Yannakou CK, Jones K, McBean M, Thompson ER, Ryland GL, Doig K, Markham J, Westerman D, Blombery P.

Blood Cancer J. 2017 Dec 15;7(12):656. doi: 10.1038/s41408-017-0025-8. No abstract available.

16.

The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain.

Bosnakovski D, Toso EA, Hartweck LM, Magli A, Lee HA, Thompson ER, Dandapat A, Perlingeiro RCR, Kyba M.

J Cell Sci. 2017 Nov 1;130(21):3685-3697. doi: 10.1242/jcs.205427. Epub 2017 Sep 21.

17.

Detection of clinically relevant early genomic lesions in B-cell malignancies from circulating tumour DNA using a single hybridisation-based next generation sequencing assay.

Blombery PA, Ryland GL, Markham J, Guinto J, Wall M, McBean M, Jones K, Thompson ER, Cameron DL, Papenfuss AT, Prince MH, Dickinson M, Westerman DA.

Br J Haematol. 2018 Oct;183(1):146-149. doi: 10.1111/bjh.14919. Epub 2017 Sep 7. No abstract available.

PMID:
28880377
18.

Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignancies.

Yannakou CK, Jones K, Ryland GL, Thompson ER, Reid G, McBean M, Trainer A, Westerman D, Blombery P.

J Clin Pathol. 2018 Jan;71(1):84-87. doi: 10.1136/jclinpath-2017-204481. Epub 2017 Aug 11.

PMID:
28801348
19.

Theta- and alpha-power enhancements in the electroencephalogram as an auditory delayed match-to-sample task becomes impossibly difficult.

Wisniewski MG, Thompson ER, Iyer N.

Psychophysiology. 2017 Dec;54(12):1916-1928. doi: 10.1111/psyp.12968. Epub 2017 Aug 9.

PMID:
28792606
20.

PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories.

Doig KD, Fellowes A, Bell AH, Seleznev A, Ma D, Ellul J, Li J, Doyle MA, Thompson ER, Kumar A, Lara L, Vedururu R, Reid G, Conway T, Papenfuss AT, Fox SB.

Genome Med. 2017 Apr 24;9(1):38. doi: 10.1186/s13073-017-0427-z.

21.

Enhanced auditory spatial performance using individualized head-related transfer functions: An event-related potential study.

Wisniewski MG, Romigh GD, Kenzig SM, Iyer N, Simpson BD, Thompson ER, Rothwell CD.

J Acoust Soc Am. 2016 Dec;140(6):EL539. doi: 10.1121/1.4972301.

PMID:
28040012
22.

Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.

Lobachevsky P, Leong T, Daly P, Smith J, Best N, Tomaszewski J, Thompson ER, Li N, Campbell IG, Martin RF, Martin OA.

Cancer Lett. 2016 Dec 28;383(2):212-219. doi: 10.1016/j.canlet.2016.09.010. Epub 2016 Sep 28.

23.

Reevaluation of RINT1 as a breast cancer predisposition gene.

Li N, Thompson ER, Rowley SM, McInerny S, Devereux L, Goode D, Investigators L, Wong-Brown MW, Scott RJ, Trainer AH, Gorringe KL, James PA, Campbell IG.

Breast Cancer Res Treat. 2016 Sep;159(2):385-92. doi: 10.1007/s10549-016-3944-3. Epub 2016 Aug 20.

PMID:
27544226
24.

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.

Blombery P, Thompson ER, Jones K, Arnau GM, Lade S, Markham JF, Li J, Deva A, Johnstone RW, Khot A, Prince HM, Westerman D.

Haematologica. 2016 Sep;101(9):e387-90. doi: 10.3324/haematol.2016.146118. Epub 2016 May 19. No abstract available.

25.

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Dennis J, Ahmad J, Thompson ER, Damiola F, Pertesi M, Voegele C, Mebirouk N, Robinot N, Durand G, Forey N, Luben RN, Ahmed S, Aittomäki K, Anton-Culver H, Arndt V; Australian Ovarian Cancer Study Group, Baynes C, Beckman MW, Benitez J, Van Den Berg D, Blot WJ, Bogdanova NV, Bojesen SE, Brenner H, Chang-Claude J, Chia KS, Choi JY, Conroy DM, Cox A, Cross SS, Czene K, Darabi H, Devilee P, Eriksson M, Fasching PA, Figueroa J, Flyger H, Fostira F, García-Closas M, Giles GG, Glendon G, González-Neira A, Guénel P, Haiman CA, Hall P, Hart SN, Hartman M, Hooning MJ, Hsiung CN, Ito H, Jakubowska A, James PA, John EM, Johnson N, Jones M, Kabisch M, Kang D; kConFab Investigators, Kosma VM, Kristensen V, Lambrechts D, Li N; Lifepool Investigators, Lindblom A, Long J, Lophatananon A, Lubinski J, Mannermaa A, Manoukian S, Margolin S, Matsuo K, Meindl A, Mitchell G, Muir K; NBCS Investigators, Nevelsteen I, van den Ouweland A, Peterlongo P, Phuah SY, Pylkäs K, Rowley SM, Sangrajrang S, Schmutzler RK, Shen CY, Shu XO, Southey MC, Surowy H, Swerdlow A, Teo SH, Tollenaar RA, Tomlinson I, Torres D, Truong T, Vachon C, Verhoef S, Wong-Brown M, Zheng W, Zheng Y, Nevanlinna H, Scott RJ, Andrulis IL, Wu AH, Hopper JL, Couch FJ, Winqvist R, Burwinkel B, Sawyer EJ, Schmidt MK, Rudolph A, Dörk T, Brauch H, Hamann U, Neuhausen SL, Milne RL, Fletcher O, Pharoah PD, Campbell IG, Dunning AM, Le Calvez-Kelm F, Goldgar DE, Tavtigian SV, Chenevix-Trench G.

J Med Genet. 2016 May;53(5):298-309. doi: 10.1136/jmedgenet-2015-103529. Epub 2016 Feb 26.

26.

Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care.

Thompson ER, Rowley SM, Li N, McInerny S, Devereux L, Wong-Brown MW, Trainer AH, Mitchell G, Scott RJ, James PA, Campbell IG.

J Clin Oncol. 2016 May 1;34(13):1455-9. doi: 10.1200/JCO.2015.63.7454. Epub 2016 Jan 19.

PMID:
26786923
27.

Modeling Two-Channel Speech Processing With the EPIC Cognitive Architecture.

Kieras DE, Wakefield GH, Thompson ER, Iyer N, Simpson BD.

Top Cogn Sci. 2016 Jan;8(1):291-304. doi: 10.1111/tops.12180. Epub 2016 Jan 8.

28.

Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context.

Thompson ER, Gorringe KL, Rowley SM, Li N, McInerny S, Wong-Brown MW, Devereux L, Li J; Lifepool Investigators, Trainer AH, Mitchell G, Scott RJ, James PA, Campbell IG.

Sci Rep. 2015 Oct 12;5:14800. doi: 10.1038/srep14800.

29.

Enhancing listener strategies using a payoff matrix in speech-on-speech masking experiments.

Thompson ER, Iyer N, Simpson BD, Wakefield GH, Kieras DE, Brungart DS.

J Acoust Soc Am. 2015 Sep;138(3):1297-304. doi: 10.1121/1.4928395.

PMID:
26428768
30.

Copy number analysis of ductal carcinoma in situ with and without recurrence.

Gorringe KL, Hunter SM, Pang JM, Opeskin K, Hill P, Rowley SM, Choong DY, Thompson ER, Dobrovic A, Fox SB, Mann GB, Campbell IG.

Mod Pathol. 2015 Sep;28(9):1174-84. doi: 10.1038/modpathol.2015.75. Epub 2015 Jun 19.

31.

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls.

Thompson ER, Gorringe KL, Rowley SM, Wong-Brown MW, McInerny S, Li N, Trainer AH, Devereux L, Doyle MA, Li J, Lupat R, Delatycki MB; LifePool Investigators, Mitchell G, James PA, Scott RJ, Campbell IG.

Breast Cancer Res. 2015 Aug 19;17:111. doi: 10.1186/s13058-015-0627-7.

32.

Frontal midline θ power as an index of listening effort.

Wisniewski MG, Thompson ER, Iyer N, Estepp JR, Goder-Reiser MN, Sullivan SC.

Neuroreport. 2015 Jan 21;26(2):94-9. doi: 10.1097/WNR.0000000000000306.

PMID:
25536119
33.

Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment.

Li J, Doyle MA, Saeed I, Wong SQ, Mar V, Goode DL, Caramia F, Doig K, Ryland GL, Thompson ER, Hunter SM, Halgamuge SK, Ellul J, Dobrovic A, Campbell IG, Papenfuss AT, McArthur GA, Tothill RW.

PLoS One. 2014 Apr 21;9(4):e95217. doi: 10.1371/journal.pone.0095217. eCollection 2014.

34.

Perceiving sequential dependencies in auditory streams.

Kidd G Jr, Mason CR, Streeter T, Thompson ER, Best V, Wakefield GH.

J Acoust Soc Am. 2013 Aug;134(2):1215-31. doi: 10.1121/1.4812276.

35.

Spatial release from masking as a function of the spectral overlap of competing talkers.

Best V, Thompson ER, Mason CR, Kidd G Jr.

J Acoust Soc Am. 2013 Jun;133(6):3677-80. doi: 10.1121/1.4803517.

36.

An energetic limit on spatial release from masking.

Best V, Thompson ER, Mason CR, Kidd G Jr.

J Assoc Res Otolaryngol. 2013 Aug;14(4):603-10. doi: 10.1007/s10162-013-0392-1. Epub 2013 May 7.

37.

Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer.

Thompson ER, Rowley SM, Sawyer S, kConfab, Eccles DM, Trainer AH, Mitchell G, James PA, Campbell IG.

PLoS One. 2013;8(1):e54772. doi: 10.1371/journal.pone.0054772. Epub 2013 Jan 25.

38.

Rare variants in XRCC2 as breast cancer susceptibility alleles.

Hilbers FS, Wijnen JT, Hoogerbrugge N, Oosterwijk JC, Collee MJ, Peterlongo P, Radice P, Manoukian S, Feroce I, Capra F, Couch FJ, Wang X, Guidugli L, Offit K, Shah S, Campbell IG, Thompson ER, James PA, Trainer AH, Gracia J, Benitez J, van Asperen CJ, Devilee P.

J Med Genet. 2012 Oct;49(10):618-20. doi: 10.1136/jmedgenet-2012-101191.

PMID:
23054243
39.

Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.

Thompson ER, Doyle MA, Ryland GL, Rowley SM, Choong DY, Tothill RW, Thorne H; kConFab, Barnes DR, Li J, Ellul J, Philip GK, Antill YC, James PA, Trainer AH, Mitchell G, Campbell IG.

PLoS Genet. 2012 Sep;8(9):e1002894. doi: 10.1371/journal.pgen.1002894. Epub 2012 Sep 27.

40.

Analysis of KLLN as a high-penetrance breast cancer predisposition gene.

Thompson ER, Gorringe KL, Choong DY, Eccles DM; kConFab, Mitchell G, Campbell IG.

Breast Cancer Res Treat. 2012 Jul;134(2):543-7. doi: 10.1007/s10549-012-2088-3. Epub 2012 May 13.

PMID:
22580995
41.

CONTRA: copy number analysis for targeted resequencing.

Li J, Lupat R, Amarasinghe KC, Thompson ER, Doyle MA, Ryland GL, Tothill RW, Halgamuge SK, Campbell IG, Gorringe KL.

Bioinformatics. 2012 May 15;28(10):1307-13. doi: 10.1093/bioinformatics/bts146. Epub 2012 Apr 2.

42.

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma.

Johnson CE, Gorringe KL, Thompson ER, Opeskin K, Boyle SE, Wang Y, Hill P, Mann GB, Campbell IG.

Breast Cancer Res Treat. 2012 Jun;133(3):889-98. doi: 10.1007/s10549-011-1835-1. Epub 2011 Nov 4.

PMID:
22052326
43.

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients.

Thompson ER, Boyle SE, Johnson J, Ryland GL, Sawyer S, Choong DY, kConFab, Chenevix-Trench G, Trainer AH, Lindeman GJ, Mitchell G, James PA, Campbell IG.

Hum Mutat. 2012 Jan;33(1):95-9. doi: 10.1002/humu.21625. Epub 2011 Nov 4.

PMID:
21990120
44.

Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease.

Shively SB, Falke EA, Li J, Tran MG, Thompson ER, Maxwell PH, Roessler E, Oldfield EH, Lonser RR, Vortmeyer AO.

Mod Pathol. 2011 Aug;24(8):1023-30. doi: 10.1038/modpathol.2011.61. Epub 2011 Apr 15.

45.

SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer.

Askarian-Amiri ME, Crawford J, French JD, Smart CE, Smith MA, Clark MB, Ru K, Mercer TR, Thompson ER, Lakhani SR, Vargas AC, Campbell IG, Brown MA, Dinger ME, Mattick JS.

RNA. 2011 May;17(5):878-91. doi: 10.1261/rna.2528811. Epub 2011 Apr 1.

46.

Suitable reverberation times for halls for rock and pop music.

Adelman-Larsen NW, Thompson ER, Gade AC.

J Acoust Soc Am. 2010 Jan;127(1):247-55. doi: 10.1121/1.3263611. Erratum in: J Acoust Soc Am. 2012 Nov;132(5):3586.

PMID:
20058970
47.

Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors.

Arnold JM, Choong DY, Thompson ER; kConFab, Waddell N, Lindeman GJ, Visvader JE, Campbell IG, Chenevix-Trench G.

Breast Cancer Res Treat. 2010 Jan;119(2):491-6. doi: 10.1007/s10549-008-0269-x. Epub 2009 Feb 3.

PMID:
19189213
48.

Race-based shifting standards and racial discrimination.

Biernat M, Collins EC, Katzarska-Miller I, Thompson ER.

Pers Soc Psychol Bull. 2009 Jan;35(1):16-28. doi: 10.1177/0146167208325195.

PMID:
19106075
49.

No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas.

Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, Trivett M, Thompson ER, Ramakrishna M, Gorringe KL, Polyak K, Haviv I, Campbell IG.

Nat Genet. 2008 May;40(5):650-5. doi: 10.1038/ng.117. Epub 2008 Apr 13.

50.

Binaural processing of modulated interaural level differences.

Thompson ER, Dau T.

J Acoust Soc Am. 2008 Feb;123(2):1017-29. doi: 10.1121/1.2821800.

PMID:
18247904

Supplemental Content

Loading ...
Support Center